Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent Influenza Split Vaccine in 6–35 Month-Old Children (Phase II)
CTR20200051Phase 2Completed
- Sponsor
- Shanghai Institute of Biological Products
- Start
- Feb 2020
- Countries
- 1
01
Overview
A Phase 2 trial of influenza virus vaccine, quadrivalent, split virion in influenza, sponsored by Shanghai Institute of Biological Products. Started Feb 2020; status: completed.
02
Drugs
influenza virus vaccine, quadrivalent, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20200051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200051.